Wegovy online kaufen – Ihre erstklassige Online-Apotheke. Bestellen Sie jetzt und erhalten Sie Ihr Paket innerhalb von nur 24 Stunden.
What is Wegovy?
Wegovy is a medication specifically developed for the treatment of overweight and obesity. It is based on the active ingredient semaglutide—also used in diabetes
medications such as Ozempic—but at a higher dosage. Unlike Ozempic, Wegovy is officially approved for weight loss in the European Union.
The medication is manufactured by the Danish pharmaceutical company Novo Nordisk and has been available in Germany since July 2023. It is administered
once weekly via subcutaneous injection (under the skin), a procedure patients can perform themselves after receiving instruction. Wegovy is prescribed for
individuals with a body mass index (BMI) of 30 or higher, or 27 or higher if accompanied by comorbidities such as high blood pressure or lipid metabolism
disorders. Before starting treatment, non-pharmacological measures—such as nutritional counseling or exercise therapy—should already have been exhausted.
“According to the S3 guideline on obesity treatment, every medication like Wegovy should always be embedded in a basic program – this includes
Nutritional therapy, exercise, and behavioral therapy. Only in this way can lasting effects be achieved. Digital programs like zanadio address precisely these points.
and enable structured, guideline-compliant treatment. Furthermore, zanadio is fully covered by all statutory health insurance funds within the BMI range.
from 30 to 40 kg/m².“
How does Wegovy work?
Wegovy contains the active ingredient semaglutide , a so-called GLP-1 receptor agonist . This substance mimics the body’s own GLP-1 hormone, which
It is released in the intestines after eating and controls various processes in the body.
More insulin is released (when blood sugar is elevated),
the release of sugar from the liver is inhibited,
Gastric emptying is slowed down – you feel full for longer,
and the feeling of satiety in the brain is increased – appetite decreases. [ 1 ]
Unlike the body’s own GLP-1, injected semaglutide is not broken down by the body within a very short time. Due to its long duration of action, it is sufficient
A weekly injection is required to maintain these effects.
How much weight can you lose with Wegovy?
In clinical studies, Wegovy showed strong effects on body weight: After 68 weeks , participants who ate a healthy diet had improved their physical condition.
Those who were active and took Wegovy lost on average about 12 to 15 percent more body weight than the control group, which received a placebo.
The key is that Wegovy works best in combination with a balanced diet and exercise. Only in this way can weight be reduced permanently.
and be held
Application of Wegovy
Wegovy is injected once a week into the subcutaneous fat tissue of the abdomen, thigh, or upper arm using a pre-filled pen. Treatment begins with
a starting dose of 0.25 mg and is gradually increased to 2.4 mg to improve tolerability and reduce side effects.
How long should Wegovy be taken for weight loss?
An initial effect is often visible after a few weeks. Current research suggests that semaglutide must be taken continuously to maintain the effect.
Maintaining weight loss is difficult. After discontinuing the medication and without lifestyle changes, weight often rebounds. Generally, an additional diet is always recommended.
Lifestyle adjustments are recommended to maintain weight sustainably.
Reviews
There are no reviews yet.